Lumos Diagnostics Holdings Ltd
Research Lumos Diagnostics Holdings Ltd (LDX) on Bullrun: market cap AUD 97.17M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLDX
- ExchangeAU
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 97.17M
- Financial periodFY2026
- RevenueUSD 13.19M
- Revenue growth5.5%
- Net income-USD 4.95M
- Gross margin59.7%
Valuation Snapshot
latest market cap is AUD 97.17M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 13.19M | -USD 4.95M | n/a | 59.7% | -0.01 | USD 15.43M | n/a | n/a |
| FY2025 | USD 12.50M | -USD 7.18M | -USD 9.39M | 63.2% | -0.01 | USD 1.96M | USD 6.99M | USD 6.16M |
| FY2024 | USD 11.13M | -USD 8.59M | USD 848.00K | 63.8% | -0.02 | USD 6.48M | USD 8.06M | USD 7.11M |
| FY2023 | USD 10.54M | -USD 8.97M | -USD 9.79M | 56.7% | -0.04 | USD 3.02M | USD 9.79M | USD 9.50M |
| FY2022 | USD 11.63M | -USD 45.72M | -USD 22.39M | 38.3% | -0.28 | USD 7.98M | USD 7.19M | USD 17.89M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | AUD 97.17M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Lumos Diagnostics Holdings Ltd
Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lumos Diagnostics Holdings Ltd's market cap?
Lumos Diagnostics Holdings Ltd's market capitalization is AUD 97.17M.
What does Lumos Diagnostics Holdings Ltd do?
Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.